How Many Patients Participated In The Capsicum Plaster Study And How Were They Divided? Key Insights

The study involved a total of 320 patients who were randomly divided into two equal groups of 160 participants each. One group received treatment with an active capsicum plaster, while the other group was given a placebo plaster. This randomized, double-blind setup ensured unbiased evaluation of the plaster's efficacy in managing pain, with outcomes measured using standardized scales and patient-reported metrics.

Key Points Explained:

Total Participants
- The study enrolled 320 patients, a sample size large enough to provide statistically significant results while maintaining manageable clinical trial logistics.
Group Division
- Randomized allocation: Patients were split into two groups of 160 each to ensure balanced comparison.
- Treatment vs. placebo:
  - Group 1: Active capsicum plaster (containing capsaicin).
  - Group 2: Placebo plaster (identical in appearance but pharmacologically inert).
- Randomization minimized bias in demographic or clinical characteristics between groups.
Study Design
- Double-blind: Neither patients nor investigators knew which plaster was active, reducing placebo effect and observer bias.
- Outcome measures: Included pain reduction (30% threshold), disability scores, and patient/investigator efficacy ratings.
Why This Matters
- Equal group sizes and randomization strengthen the reliability of conclusions about the plaster’s effectiveness.
- The design mirrors real-world clinical decision-making, where clear evidence of superiority over placebo is critical for adoption.

This structured approach highlights how rigorous methodology supports evidence-based recommendations for pain management tools like capsicum plaster.

Summary Table:

Aspect	Details
Total Participants	320 patients
Group Division	160 patients (active capsicum plaster) vs. 160 (placebo)
Study Design	Randomized, double-blind, with standardized pain/disability metrics
Key Outcome	30% pain reduction threshold, efficacy ratings by patients/investigators

Need clinically validated pain relief solutions? Partner with Enokon, a trusted bulk manufacturer of transdermal patches and pain plasters. Our expertise in custom R&D ensures evidence-backed formulations tailored to your brand or distribution needs. Contact us today to discuss scalable, compliant solutions for your market.